SEARCH

SEARCH BY CITATION

References

  • Ackermann, S., Klumpp, T., Guzman, G.I., Herman, J., Gaughan, J., Bleecker, G. & Mangan, K. (2000) Economic consequences of alterations in platelet transfusion dose: analysis of prospective, randomised, double blind trial. Transfusion, 40, 14571462 .DOI: 10.1046/j.1537-2995.2000.40121457.x
  • Beutler, E. (1993) Platelet transfusions: The 20,000 trigger – Editorial. Blood, 81, 14111413.
  • Contreras, M. (1998) Final statement from the consensus conference on platelet transfusion– Royal College of Physicians, Edinburgh. Transfusion, 38, 796797.
  • Gaydos, L.A., Freireich, E.J. & Mantel, N. (1962) The quantitative relation between platelet count and haemorrhage in patients with acute leukaemia. New England Journal of Medicine, 266, 905909.
  • Gil Fernandez, J.J., Alegre, A., Fernandez, M., Pinilla, I., Garcia, V., Martinez, C., Tomas, J., Arranz, R., Figuera, A., Camara, R. & Fernandez, J. (1996) Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomised comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplantation, 18, 931935.
  • Gmur, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet, 338, 12231226.
  • National Institutes of Health (1987) Consensus development conference on platelet transfusion therapy. Journal of the American Medical Association, 257, 17771780.
  • Patten, E. (1992) Controversies in transfusion medicine: prophylactic platelet transfusion revisited after 25 years: con. Transfusion, 32, 381385.
  • Pisciotto, P., Benson, K. & Hume, H. (1995) Prophylactic versus therapeutic platelet transfusion practices in haematology and/or oncology patients. Transfusion, 35, 498502.
  • Rebulla, P., Finazzi, G., Marangoni, F., Avvisati, G., Gugliotta, L., Tongnoni, G., Barbui, T., Mandelli, F. & Sirchia, G. (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukaemia. New England Journal of Medicine, 337, 18701875.